Dan Conn

Dan Conn is the Chief Financial Officer at Tvardi Therapeutics, Inc., a position he assumed in January 2022.2 He is a seasoned executive with an extensive background in corporate law, finance, and business management.13

Professional Background

Mr. Conn's career trajectory includes:

1. Legal Career: He began his professional journey as an M&A and securities lawyer.1

2. Investment Banking:

   • Worked as an Executive Director at Morgan Stanley
   • Served as a Director at PJ Solomon
   • Focused on M&A, restructuring, and financing transactions in life sciences and other industries1

3. Investment Management:

   • Vice President and Portfolio Manager at DE Shaw & Co
   • Senior Vice President and Portfolio Manager at Brookfield Asset Management
   • Invested in multiple industries, including life sciences1

4. Intellectual Property: Prior to joining Tvardi, he directed the development and monetization of intellectual property rights.1

Education

Dan Conn holds both legal and business degrees:

• J.D. (Juris Doctor)
• M.B.A. in Finance (1997-1999)4

Role at Tvardi Therapeutics

As CFO at Tvardi Therapeutics, Conn brings his extensive experience in finance, law, and business management to a company focused on developing breakthrough therapies for cancer and inflammatory diseases.1 His diverse background in investment banking, asset management, and intellectual property makes him well-suited to guide the financial strategy of a clinical-stage biopharmaceutical company.